BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$8.49
Tradestie Score
45
Market Cap
$212.23M
Revenue Growth
0.0%
Analyst Upside
+319.6%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
ZBIO Zenas BioPharma, Inc. Common Stock
$31.12
$931.48M - 43 Compare
MBX MBX Biosciences, Inc. Common Stock
$59.02
$800.41M - 57 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.78
$711.32M - 40 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$57.08
$543.32M 152.3 43 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$14.07
$463.20M - 65 Compare
ALMS Alumis Inc. Common Stock
$9.18
$422.50M - 53 Compare
EOLS Evolus, Inc. Common Stock
$7.84
$397.82M - 35 Compare
KYTX Kyverna Therapeutics, Inc. Common Stock
$7.26
$258.18M - 41 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.08
$237.15M 5.2 53 Compare

Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry